nach oben

Erschienen in:

01.07.2012 | case report

Attempted suicide under high dose dopaminergic therapy including apomorphine

verfasst von: Walter Struhal, MD, Michael Guger, MD, Stephanie Hödl, MD, Sok-Chu Ung, MD, Prof Michael Bach, MD, Prof. Gerhard Ransmayr, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2012

Einloggen, um Zugang zu erhalten

Summary

Impulse control disorder during continuous subcutaneous apomorphine treatment (CAI) was recently reported. We describe a 54-year-old patient with familial Parkinson’s disease, who after initiation of CAI in addition to high dose levodopa and amantadine, developed impulse control disorder (major financial loss related to risky transactions and self-medication), psychosis and depression, which lead up to attempted suicide. To our knowledge, this is the first case of attempted suicide under apomorphine treatment.

Vorheriger Artikel Intraindividual differences between two simultaneous glucose measurement systems in type 2 diabetic patients

Nächster Artikel Es ist so weit!

Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology. 2006;66:1750–2.PubMedCrossRef

Soulas T, Gurruchaga JM, Palfi S, Cesaro P, Nguyen JP, Fenelon G. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2008;79:952–4.PubMedCrossRef

Bxarone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:573–80.CrossRef

Parkinson Study Group. Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: a randomized controlled trial. JAMA. 2000;284:1931–8.CrossRef

Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry.2008;192:98–105.PubMedCrossRef

Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in finnish patients with Parkinson’s disease. Parkinsonism.Relat Disord. 2011;18(2):155–60.PubMedCrossRef

Stamey W, Jankovic J. Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist. 2008;14:89–99.PubMedCrossRef

Antonini A. Continuous dopaminergic stimulation–from theory to clinical practice. Parkinsonism.Relat Disord. 2007;(13 Suppl):S24–8.CrossRef

Poewe W. When a Parkinson’s disease patient starts to hallucinate. Pract Neurol. 2008;8:238–41.PubMedCrossRef

Titel: Attempted suicide under high dose dopaminergic therapy including apomorphine
verfasst von: Walter Struhal, MD
Michael Guger, MD
Stephanie Hödl, MD
Sok-Chu Ung, MD
Prof Michael Bach, MD
Prof. Gerhard Ransmayr, MD
Publikationsdatum: 01.07.2012
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 13-14/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-012-0202-5

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 13-14/2012

Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin

Effective penile block for circumcision in adults

Österreichische Gesellschaft für Endokrinologie und Stoffwechsel

Evaluation of biochemical, hematological, and thyroid function parameters in nondipper and dipper hypertensive patients

Es ist so weit!

Programmvorschau